Loader
Loading Pathway...
Abciximab Abciximab Abciximab Abciximab Integrin alpha-IIb Integrin beta-3 Fibrinogen Integrin alpha-IIb Integrin beta-3 von Willebrand Factor Integrin alpha-IIb Integrin beta-3 Integrin alpha-IIb Integrin beta-3 Abciximab Abciximab Activated Platelet Binding of Abciximab causes steric hindrance or conformational alteration of integrins, preventing other binding. Activated Platelet Blocking the binding of fibrinogen blocks bridging of platelets, preventing platelet aggregation. Blocking the binding of von Willebrand factor prevents platelet aggregation and adhesion Blood Vessel Abciximab is administered intravenously and travels directly into the bloodstream
Melanosome Unknown Unknown Unknown Unknown ITGA2B Unknown FGG ITGA2B Unknown VWF ITGA2B Unknown ITGA2B Unknown Unknown Unknown
ITGA2B FGG ITGA2B VWF ITGA2B ITGA2B Activated Platelet Binding of Abciximab causes steric hindrance or conformational alteration of integrins, preventing other binding. Activated Platelet Blocking the binding of fibrinogen blocks bridging of platelets, preventing platelet aggregation. Blocking the binding of von Willebrand factor prevents platelet aggregation and adhesion Blood Vessel Abciximab is administered intravenously and travels directly into the bloodstream
Melanosome ITGA2B FGG ITGA2B VWF ITGA2B ITGA2B